Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2000 1
2002 29
2003 34
2004 46
2005 76
2006 65
2007 82
2008 93
2009 150
2010 158
2011 218
2012 276
2013 336
2014 388
2015 413
2016 454
2017 483
2018 669
2019 772
2020 971
2021 1045
2022 1428
2023 1327
2024 700

Text availability

Article attribute

Article type

Publication date

Search Results

9,151 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW; VICTORIA Study Group. Lam CSP, et al. JAMA Cardiol. 2021 Jun 1;6(6):706-712. doi: 10.1001/jamacardio.2020.6455. JAMA Cardiol. 2021. PMID: 33185650 Free PMC article. Clinical Trial.
TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
Xiao MC, Jiang N, Chen LL, Liu F, Liu SQ, Ding CH, Wu SH, Wang KQ, Luo YY, Peng Y, Yan FZ, Zhang X, Qian H, Xie WF. Xiao MC, et al. Among authors: zhang x. J Hepatol. 2024 May;80(5):778-791. doi: 10.1016/j.jhep.2023.12.029. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38237865
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Among authors: zhang x. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
Seeing Is Believing: Advances in Biological Imaging.
Zhang X, Booker SJ. Zhang X, et al. ACS Bio Med Chem Au. 2024 Jan 30;4(1):1-3. doi: 10.1021/acsbiomedchemau.3c00075. eCollection 2024 Feb 21. ACS Bio Med Chem Au. 2024. PMID: 38404744 Free PMC article. No abstract available.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Among authors: zhang x. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Static magnetic fields in regenerative medicine.
Xie W, Song C, Guo R, Zhang X. Xie W, et al. Among authors: zhang x. APL Bioeng. 2024 Mar 13;8(1):011503. doi: 10.1063/5.0191803. eCollection 2024 Mar. APL Bioeng. 2024. PMID: 38486824 Free PMC article. Review.
9,151 results